From: Omentin-1: a biomarker in large artery ischaemic stroke patients
 |  | Stroke patients | Control subjects | ||
---|---|---|---|---|---|
Diabetic | Non-diabetic | Diabetic | Non-diabetic | ||
Age in years | Range | 49–72 | 48–75 | 49–72 | 48–75 |
M±SD | 60.8±6.56 | 62.28±6.91 | 59.56±6.84 | 61.08±6.83 | |
f-value | 0.676 | ||||
p-value | 0.569 | ||||
BMI | Range | 27.5–41.3 | 29.7–41.21 | 27.7–35.6 | 27.6–38.9 |
M±SD | 30.92±2.58 | 34.02±3.44 | 31.11±2.00 | 32.41±3.19 | |
f-value | 6.254 | ||||
p-value | 0.001* | ||||
HbA1c on admission | Range | 6.9–9.8 | 4.1–5.4 | 6.9–9.1 | 4.1–5.2 |
M±SD | 8.02±0.71 | 4.74±0.38 | 7.77±0.56 | 4.69±0.34 | |
f-value | 308.13 | ||||
p-value | 0.0001* |